Delta 9 Cannabis Inc. (DN.TO)
- Previous Close
0.0250 - Open
0.0250 - Bid 0.0200 x --
- Ask 0.0250 x --
- Day's Range
0.0200 - 0.0250 - 52 Week Range
0.0150 - 0.0800 - Volume
540,600 - Avg. Volume
840,103 - Market Cap (intraday)
6.541M - Beta (5Y Monthly) 1.34
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1000 - Earnings Date May 13, 2024 - May 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.80
Delta 9 Cannabis Inc., together with its subsidiaries, operates as an integrated cannabis company. The company engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. The company operates retail stores under the Delta 9 brand name across the Canadian provinces. It also exports its products to Australia. The company was incorporated in 2001 and is based in Vancouver, Canada.
www.delta9.ca200
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: DN.TO
Performance Overview: DN.TO
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DN.TO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DN.TO
Valuation Measures
Market Cap
6.54M
Enterprise Value
68.99M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.06
Price/Book (mrq)
--
Enterprise Value/Revenue
0.97
Enterprise Value/EBITDA
-66.19
Financial Highlights
Profitability and Income Statement
Profit Margin
-24.65%
Return on Assets (ttm)
-10.31%
Return on Equity (ttm)
-29,673.63%
Revenue (ttm)
71.07M
Net Income Avi to Common (ttm)
-17.52M
Diluted EPS (ttm)
-0.1000
Balance Sheet and Cash Flow
Total Cash (mrq)
2.15M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
3.63M